Full Press Release Details
2815 Eastlake Avenue, Suite 300
Please accept this letter as formal notification that I hereby resign my positions as Chief Financial Officer and Member of the Board of Directors effective immediately.
MRKR
Glynn Wilson Chairman & CEO TapImmune Inc. 2815 Eastlake Avenue, Suite 300 Seattle, WA 98102
Key Takeaway: 2815 Eastlake Avenue, Suite 300
Please accept this letter as formal notification that I hereby resign my positions as Chief Financial Officer and Member of the Board of Directors effective immediately.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+35%
120-day peak, hindsight
Typical move
5.1%
average across 5 past catalysts
Cash runway
~9 mo
Medium dilution risk
Lead asset
Low dose FRα vaccine
Phase 2 · Breast Cancer